Ticker
KRROCompany Name
KORRO BIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Total Debt | Debt to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 180.43M | $ 44.63M | 24.74% |
3/31/2025 | $ 202.21M | $ 45.19M | 22.35% |
12/31/2024 | $ 226.24M | $ 44.77M | 19.79% |
9/30/2024 | $ 243.54M | $ 41.78M | 17.16% |
6/30/2024 | $ 249.59M | $ 38.46M | 15.41% |
3/31/2024 | $ 197.99M | $ 35.92M | 18.14% |
12/31/2023 | $ 221.66M | $ 33.21M | 14.98% |
9/30/2023 | $ 46.35M | $ 1.43M | 3.08% |
6/30/2023 | $ 79.38M | $ 27.81M | 35.03% |
3/31/2023 | $ 101.5M | $ 39.97M | 39.38% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt / Assets
(=) Debt to Assets
Debt to Assets for KORRO BIO INC is calculated as follows: Debt [ $ 2.24M ] / Assets [ $ 234.32M ]
(=) Debt to Assets [ 0.96% ]
Minimum
Sep 30, 2020
Maximum
Mar 31, 2023
Average
Median
filtered constituents | 4.38K |
---|---|
min | 0% |
max | 116.6% |
average | 26.32% |
median | 21.04% |
std | 24.49% |